Colorectal cancer (CRC) is the second leading cause of cancer-associated mortality
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …

ABSTRACT Background Circulating microRNAs (miRNAs) are attracting major interest as
potential non-invasive biomarkers for colorectal cancer (CRC). This study aimed to identify a …

Circulating microRNAs (miRNAs) are emerging as promising biomarkers for colorectal
cancer (CRC). In this study, we sought to examine the diagnostic and prognostic role of …

BACKGROUND: Colorectal cancer (CRC) is a common type of cancer around the world.
Detection of microRNA (miRNA) aberration in blood samples is a novel approach for CRC …

Aberrant levels of circulating microRNAs are potential biomarkers for the early detection of
colorectal cancer. The aim of this study was to study miR-139-3p and miR-622 in serum as a …

Circulating microRNAs are novel and non-invasive tumor biomarkers for colorectal cancer
(CRC) detection. In this study, we investigated miR-372 expression in serum and tissues in …

BACKGROUND: Colorectal cancer (CRC) is one of the most prevalent cancers and
microRNAs are involved in colorectal carcinogenesis and progression. The role of our …

Colorectal cancer (CRC) is one of the most common cancers worldwide, with high mortality.
Abnormally expressed microRNAs (miRNAs) are considered novel biomarkers in cancer …

It has been demonstrated that there are abundant stable microRNAs (miRNAs) in
plasma/serum, which can be detected and are potentially disease‑specific. The aim of this …

Background. Colorectal cancer (CRC) is one of the leading causes of cancer death
worldwide. Successful treatment of CRC relies on accurate early diagnosis, which is …